HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders
Breast Cancer Update
00:00
Tolerability differences and GI side effects
Detailed discussion of GI dyspepsia-like effects, dose reductions, and why combinations amplify toxicity concerns.
Play episode from 18:31
Transcript
